Observatorio de I+D+i UPM

Ficha de consulta Proyectos OPE
  CONTACT DETAILS      
 

UPM MAIN RESEARCHER
Maria Teresa Arredondo Waldmeyer
E.T.S. DE INGENIEROS DE TELECOMUNICACION
e-mail

 
COORDINADOR
PHILIPS TECHNOLOGIE GMBH (DE)
 
PARTICIPANTS
ARISTOTELIO PANEPISTIMIO THESSALONIKIS (GR)
Clothing Plus (FI)
CSEM - Centre Suisse d Electronique et de Microtechnique S.A. (CH)
DEUTSCHE SPORTHOCHSCHULE KOLN (DE)
Empirica (AT)
FUNDACIO INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES)
Fundación Vodafone España (ES)
Hospital Clínico San Carlos de Madrid (ES)
Universidad Politécnica de Valencia (ES)
Linkopings Universitet (SE)
LOTHIAN HEALTH BOARD (UK)
Medtronic Iberica (ES)
PHILIPS ELECTRONICS NEDERLAND B.V. (NL)
Politecnico di Milano (IT)
RWTH Aachen University (DE)
SERVICIO MADRILEÑO DE SALUD - SERMAS (ES)
Teknologian Tutkimuskeskus VTT Oy (FI)
The Chinese University of Hong Kong (CN)
University of Hull (UK)
T-Systems ITC Iberia (ES)
UNIVERSIDAD POLITECNICA DE MADRID (ES)
UC - UNIVERSIDADE DE COIMBRA (PT)
Universidade de Coimbra (PT)
UNIVERSITAETSKLINIKUM HEIDELBERG (DE)
 
 
 
HEARTCYCLE
http://www.heartcycle.eu
Compliance and effectiveness in HF and CHD closed-loop management
 
COOPERATION ICT
ICT-2007.5.1 Personal Health Systems for Monitoring and Point-of-Care diagnostics
Funding Scheme: SmallMediumProject
 
Duration: 01/03/2008 - 31/08/2013
Project cost: 21.979.604 €
 
Project description
 

Each year Cardiovascular Disease (CVD) causes over 1.9 million deaths in the EU, causing direct health costs of €105 billion. Coronary Heart Disease (CHD), half of all CVD deaths, is the single most cause of death in Europe. Heart Failure (HF) ¿ a CHD being the most frequent cause of hospitalization for people over 65 ¿ has 10 million patients in the EU. Current treatment of HF entails recommendations from clinicians on medication, diet and lifestyle. Patients only receive feedback at doctors visits, or when facing symptoms. Daily monitoring, close follow up, and help on treatment routine is lacking. Non-adherence to the treatment regime is a major cause of suboptimal clinical benefit. HeartCycle will provide a closed-loop disease management solution to serve both HF and CHD patients, including hypertension, diabetes and arrhythmias as possible comorbidities. This will be achieved by multi-parametric monitoring of vital signs, analysing the data and providing automated decision support, to derive therapy recommendations. The system will contain a patient loop interacting directly with the patient to support the daily treatment. It will show the health development, including treatment adherence and effectiveness. Being motivated, compliance will increase, and health will improve. The system will also contain a professional loop involving medical professionals, e.g. alerting to revisit the care plan. The patient loop is connected with hospital information systems, to ensure optimal and personalised care. Europe¿s health system is undergoing radical changes due to an aging population. It`s moving from reactive towards preventative care, and from hospital care to care at home. Tomorrow¿s patients will become more empowered to take their health into their own hands. New ICT is required to enable this paradigm shift. HeartCycle, coordinated by Philips ¿ leading in electronics and health care ¿, includes experts on textiles, ICT, decision support and user interaction.

 
 
S2i 2022 Observatorio de investigación @ UPM con la colaboración del Consejo Social UPM
Cofinanciación del MINECO en el marco del Programa INNCIDE 2011 (OTR-2011-0236)
Cofinanciación del MINECO en el marco del Programa INNPACTO (IPT-020000-2010-22)